Irinotecan liposome injection combined with 5-FU/leucovorin and oxaliplatin prolonged OS compared with nab-paclitaxel and gemcitabine as initial treatment for patients with metastatic pancreatic ductal adenocarcinoma, study results showed.The irinotecan liposome injection regimen, known as NALIRIFOX, also exhibited a manageable safety profile consistent with that of each treatment component,